REQUEST A DEMO
Total
USD $0.00
Search more companies

Fda Lab E U (Colombia)

Main Activities: Scientific Research and Development Services
Full name: Fda Lab E U Profile Updated: April 15, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English & Spanish Download a sample report

Fda Lab E U is an enterprise based in Colombia. Its main office is in Bogota D.C.. The enterprise operates in the Scientific Research and Development Services industry. The company was established on April 27, 2000. 30 (2024) employees currently work for Fda Lab E U. From the latest financial highlights, Fda Lab E U reported a net sales revenue increase of 54.45% in 2023. Its’ total assets recorded a negative growth of 7.02%. The enterprise’s net profit margin increased by 16.74% in 2023.

Headquarters
Calle 20 A 43 A 50 Int 6
Bogota D.C.; Bogota D.C; Postal Code: 0607

Contact Details: Purchase the Fda Lab E U report to view the information.

Basic Information
Total Employees:
Purchase the Fda Lab E U report to view the information.
Outstanding Shares:
Purchase the Fda Lab E U report to view the information.
Incorporation Date:
April 27, 2000
Key Executives
Purchase this report to view the information.
Legal Representative
Purchase this report to view the information.
Alternate Legal Representative
Ownership Details
Purchase this report to view the information.
Company Performance
Financial values in the chart are available after Fda Lab E U report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency COP. Absolute financial data is included in the purchased report.
Net sales revenue
54.45%
Total operating revenue
54.45%
Operating profit (EBIT)
332.3%
Net Profit (Loss) for the Period
424.62%
Total assets
-7.02%
Total equity
62.34%
Operating Profit Margin (ROS)
23.6%
Net Profit Margin
16.74%
Return on Equity (ROE)
50.96%
Quick Ratio
-1.22%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?